Literature DB >> 10720109

Relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Glut1 overexpression in Barrett metaplasia.

M Younes1, J Lechago, S Chakraborty, M Ostrowski, M Bridges, F Meriano, D Solcher, A Barroso, D Whitman, J Schwartz, C Johnson, A C Schmulen, R Verm, A Balsaver, N Carlson, A Ertant.   

Abstract

BACKGROUND: There is a need for molecular markers of malignant progression in Barrett metaplasia (BM). The aim of this study is to determine the relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Glut1 in BM.
METHODS: Sections of esophageal biopsy specimens from 120 patients with BM were evaluated for dysplasia, p53 protein, and Glut1 expression by immunohistochemistry, and DNA ploidy by Feulgen stain and image analysis. In cases with diploid DNA histograms, the percentage cells in the G0G1 and G2M phases of the cell cycle were determined.
RESULTS: Of 108 diploid cases 19 (28%) of 69 cases with G0G1 > or = 90% or G2M > or = 8.33% were p53-positive, in contrast to only 1 (3%) of 39 cases with lower G0G1 or G2M (P = 0.0008). Of 32 p53-positive cases 11 (32%) were aneuploid, in contrast to none (0%) of 88 p53-negative cases (P < 0.0001). Ten (91%) of 11 aneuploid cases were high-grade dysplasial adenocarcinoma (HGD/CA), compared with only 1 (1%) of 109 diploid cases (P < 0.0001). Five (45%) of 11 cases with HGD/CA were Glut1-positive, in contrast to none (0%) of 109 cases without HGD/CA (P < 0.0001).
CONCLUSIONS: Our data strongly suggest that in BM, after oxidative DNA damage, as a result of gastroesophageal reflux, there is an increase in the percentage of cells in the G0G1 or G2M phases of the cell cycle to enable repair of damaged DNA; in some of these cases this is followed sequentially by p53 gene mutation and protein accumulation, DNA aneuploidy, HGD, and CA with or without Glut1 overexpression. These events can be detected in routinely processed biopsy samples.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720109     DOI: 10.1080/003655200750024281

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  p53 protein accumulation predicts malignant progression in Barrett's metaplasia: a prospective study of 275 patients.

Authors:  Mamoun Younes; Keith Brown; Gregory Y Lauwers; Gulchin Ergun; Frank Meriano; A Carl Schmulen; Alberto Barroso; Atilla Ertan
Journal:  Histopathology       Date:  2017-04-11       Impact factor: 5.087

2.  Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.

Authors:  E A Griffiths; S A Pritchard; S M McGrath; H R Valentine; P M Price; I M Welch; C M L West
Journal:  Br J Cancer       Date:  2007-04-17       Impact factor: 7.640

3.  Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists.

Authors:  Harsha Moole; Jaymon Patel; Zohair Ahmed; Abhiram Duvvuri; Sreekar Vennelaganti; Vishnu Moole; Sowmya Dharmapuri; Raghuveer Boddireddy; Pratyusha Yedama; Naveen Bondalapati; Achuta Uppu; Prashanth Vennelaganti; Srinivas Puli
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

4.  Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma.

Authors:  S H Doak; G J S Jenkins; E M Parry; A P Griffiths; V Shah; J N Baxter; J M Parry
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.